Evidence map›Paper›PMID 35033375›Full record

ArticleJournal francais d'ophtalmologie2022

Sinopharm COVID-19 vaccine-induced Stevens-Johnson syndrome.

L Boualila, B Mrini, A Tagmouti, N El Moubarik, M Benchekroun Belabbes, N Boutimzine, L O Cherkaoui

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal francais d'ophtalmologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

L BoualilaDepartment of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco. Electronic address: l.boualila@um5s.net.ma.
B MriniDepartment of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
A TagmoutiDepartment of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
N El MoubarikDepartment of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
M Benchekroun BelabbesDepartment of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
N BoutimzineDepartment of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
L O CherkaouiDepartment of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
Hôpital Ibn Sina-Rabat · MAIbn Sina Hospital · KW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Stevens-Johnson SyndromeCOVID-19 VaccinesHumansCOVID-19 Vaccines

Identifiers

PMID35033375
PMCPMC8733279
OpenAlexW4205811408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.